These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12913072)

  • 1. Global disruption of the cerebellar transcriptome in a Down syndrome mouse model.
    Saran NG; Pletcher MT; Natale JE; Cheng Y; Reeves RH
    Hum Mol Genet; 2003 Aug; 12(16):2013-9. PubMed ID: 12913072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse.
    Baxter LL; Moran TH; Richtsmeier JT; Troncoso J; Reeves RH
    Hum Mol Genet; 2000 Jan; 9(2):195-202. PubMed ID: 10607830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Widespread cerebellar transcriptome changes in Ts65Dn Down syndrome mouse model after lifelong running.
    Walus M; Kida E; Rabe A; Albertini G; Golabek AA
    Behav Brain Res; 2016 Jan; 296():35-46. PubMed ID: 26304719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down syndrome mouse models Ts65Dn, Ts1Cje, and Ms1Cje/Ts65Dn exhibit variable severity of cerebellar phenotypes.
    Olson LE; Roper RJ; Baxter LL; Carlson EJ; Epstein CJ; Reeves RH
    Dev Dyn; 2004 Jul; 230(3):581-9. PubMed ID: 15188443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression signature of cerebellar hypoplasia in a mouse model of Down syndrome during postnatal development.
    Laffaire J; Rivals I; Dauphinot L; Pasteau F; Wehrle R; Larrat B; Vitalis T; Moldrich RX; Rossier J; Sinkus R; Herault Y; Dusart I; Potier MC
    BMC Genomics; 2009 Mar; 10():138. PubMed ID: 19331679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional disruptions in Down syndrome: a case study in the Ts1Cje mouse cerebellum during post-natal development.
    Potier MC; Rivals I; Mercier G; Ettwiller L; Moldrich RX; Laffaire J; Personnaz L; Rossier J; Dauphinot L
    J Neurochem; 2006 Apr; 97 Suppl 1():104-9. PubMed ID: 16635258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cerebellar transcriptome during postnatal development of the Ts1Cje mouse, a segmental trisomy model for Down syndrome.
    Dauphinot L; Lyle R; Rivals I; Dang MT; Moldrich RX; Golfier G; Ettwiller L; Toyama K; Rossier J; Personnaz L; Antonarakis SE; Epstein CJ; Sinet PM; Potier MC
    Hum Mol Genet; 2005 Feb; 14(3):373-84. PubMed ID: 15590701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trisomy for the Down syndrome 'critical region' is necessary but not sufficient for brain phenotypes of trisomic mice.
    Olson LE; Roper RJ; Sengstaken CL; Peterson EA; Aquino V; Galdzicki Z; Siarey R; Pletnikov M; Moran TH; Reeves RH
    Hum Mol Genet; 2007 Apr; 16(7):774-82. PubMed ID: 17339268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pattern of congenital heart defects arising from reduced Tbx5 expression is altered in a Down syndrome mouse model.
    Polk RC; Gergics P; Steimle JD; Li H; Moskowitz IP; Camper SA; Reeves RH
    BMC Dev Biol; 2015 Jul; 15():30. PubMed ID: 26208718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased male reproductive success in Ts65Dn "Down syndrome" mice.
    Moore CS; Hawkins C; Franca A; Lawler A; Devenney B; Das I; Reeves RH
    Mamm Genome; 2010 Dec; 21(11-12):543-9. PubMed ID: 21110029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overlapping trisomies for human chromosome 21 orthologs produce similar effects on skull and brain morphology of Dp(16)1Yey and Ts65Dn mice.
    Starbuck JM; Dutka T; Ratliff TS; Reeves RH; Richtsmeier JT
    Am J Med Genet A; 2014 Aug; 164A(8):1981-1990. PubMed ID: 24788405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-trisomic homeobox gene expression during craniofacial development in the Ts65Dn mouse model of Down syndrome.
    Billingsley CN; Allen JR; Baumann DD; Deitz SL; Blazek JD; Newbauer A; Darrah A; Long BC; Young B; Clement M; Doerge RW; Roper RJ
    Am J Med Genet A; 2013 Aug; 161A(8):1866-74. PubMed ID: 23843306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of trisomy on brain shape and volume in related aneuploid mouse models.
    Aldridge K; Reeves RH; Olson LE; Richtsmeier JT
    Am J Med Genet A; 2007 May; 143A(10):1060-70. PubMed ID: 17431903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental instability of the cerebellum and its relevance to Down syndrome.
    Shapiro BL
    J Neural Transm Suppl; 2001; (61):11-34. PubMed ID: 11771737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome.
    Amano K; Sago H; Uchikawa C; Suzuki T; Kotliarova SE; Nukina N; Epstein CJ; Yamakawa K
    Hum Mol Genet; 2004 Jul; 13(13):1333-40. PubMed ID: 15138197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down syndrome gene dosage imbalance on cerebellum development.
    Moldrich RX; Dauphinot L; Laffaire J; Rossier J; Potier MC
    Prog Neurobiol; 2007 Jun; 82(2):87-94. PubMed ID: 17408845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal mineralization of the Ts65Dn Down syndrome mouse appendicular skeleton begins during embryonic development in a Dyrk1a-independent manner.
    Blazek JD; Malik AM; Tischbein M; Arbones ML; Moore CS; Roper RJ
    Mech Dev; 2015 May; 136():133-42. PubMed ID: 25556111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parallels of craniofacial maldevelopment in Down syndrome and Ts65Dn mice.
    Richtsmeier JT; Baxter LL; Reeves RH
    Dev Dyn; 2000 Feb; 217(2):137-45. PubMed ID: 10706138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mouse brain transcriptome by SAGE: differences in gene expression between P30 brains of the partial trisomy 16 mouse model of Down syndrome (Ts65Dn) and normals.
    Chrast R; Scott HS; Papasavvas MP; Rossier C; Antonarakis ES; Barras C; Davisson MT; Schmidt C; Estivill X; Dierssen M; Pritchard M; Antonarakis SE
    Genome Res; 2000 Dec; 10(12):2006-21. PubMed ID: 11116095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
    García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
    Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.